Table 2.
Clinical feature | Src expression | p-Src expression | ||||
---|---|---|---|---|---|---|
Expression | Low expression | P | Expression | Low expression | P | |
Age (years) | 0.268 | 0.310 | ||||
≤50 | 42 | 25 | 44 | 23 | ||
>50 | 31 | 18 | 31 | 18 | ||
Gender | 0.949 | 0.789 | ||||
Male | 41 | 30 | 42 | 29 | ||
Female | 32 | 13 | 33 | 12 | ||
Histological type | 0.146 | 0.120 | ||||
Osteoblastic | 35 | 15 | 37 | 13 | ||
Chondroblastic | 13 | 11 | 14 | 10 | ||
Fibroblastic | 12 | 8 | 12 | 8 | ||
Telangiectatic | 7 | 8 | 7 | 8 | ||
Mixed | 6 | 1 | 5 | 2 | ||
Primary site | 0.889 | 0.584 | ||||
Femur | 28 | 15 | 30 | 13 | ||
Tibia | 19 | 15 | 20 | 14 | ||
Humerus | 13 | 8 | 13 | 8 | ||
Fibula | 4 | 1 | 2 | 3 | ||
Ilium | 5 | 2 | 6 | 1 | ||
Other | 4 | 2 | 4 | 2 | ||
Metastasis | 0.044* | 0.020* | ||||
Yes | 51 | 22 | 53 | 20 | ||
No | 22 | 21 | 22 | 21 | ||
Clinical stage | 0.0004* | 0.0005* | ||||
Stage I B | 2 | 3 | 2 | 3 | ||
Stage II A | 3 | 14 | 4 | 13 | ||
Stage II B | 40 | 24 | 40 | 24 | ||
Stage III | 28 | 2 | 29 | 1 |
P<0.05.